Hiroaki Shiba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroaki Shiba has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Katsuhiko Yanaga
Department of Surgery The Jikei University School of Medicine Tokyo Japan
41 shared publications - Kenei Furukawa
Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
29 shared publications - Takeyuki Misawa
Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan
27 shared publications - Koichiro Haruki
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
25 shared publications - Yuki Fujiwara
Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, USA
22 shared publications Shigeki Wakiyama
Department of Surgery, The Jikei University of Medicine
16 shared publications
Latest Publications
- 20 May 2018
- Published by Japan Society of Hepatology in Kanzo
- Vol. 59 (5) , 237-242
Initial 10 cases of living-donor liver transplantation for primary biliary cholangitis at Jikei University Hospital
- 20 May 2018
- Published by Japan Society of Hepatology in Kanzo
- Vol. 59 (5) , 237-242
Initial 10 cases of living-donor liver transplantation for primary biliary cholangitis at Jikei University Hospital
- 1 January 2018
- Published by International College of Surgeons in International Surgery
- Vol. 105 (1-3) , 342-345
Laparoscopic Cholecystectomy With Medial Segment Artery Mimicking Cystic Artery
Introduction: Laparoscopic cholecystectomy (LC) is the gold standard treatment for cholelithiasis. However, LC is associated with a slightly higher rate of complications than laparotomy. To perform a safe LC, it is important to exercise caution regarding an abnormal course for the hepatic artery, although the incidence itself is low. Here, we report a rare case of LC in which the medial segment artery mimicked cystic artery. To the best of our knowledge, such a case has not yet been reported. Case Presentation: A 35-year-old man visited our hospital with a complaint of epigastric pain. The symptom had continued for 2 months. Ultrasound and computed tomography revealed cholelithiasis. Magnetic resonance imaging did not show any biliary abnormalities. The patient was scheduled for an elective laparoscopic cholecystectomy. At the time of surgery, the gallbladder was slightly inflamed. After dissection of the Calot triangle, the cystic duct and a single large artery were identified. Although the critical view of safety was confirmed at first glance, dissection of periarterial adhesions revealed that the artery ran into the medial segment of the liver. Further dissection revealed short double cystic arteries branching from the aberrant artery. After the confirmation of the abnormal course of the arteries, the operation was performed safely without arterial injury. The patient made a satisfactory recovery and was discharged 3 days after operation. Conclusion: The knowledge of the anatomy of the cystic artery and careful dissection are an important aspect in achieving a complication-free LC.
- 1 January 2018
- Published by International College of Surgeons in International Surgery
- Vol. 105 (1-3) , 342-345
Laparoscopic Cholecystectomy With Medial Segment Artery Mimicking Cystic Artery
Introduction: Laparoscopic cholecystectomy (LC) is the gold standard treatment for cholelithiasis. However, LC is associated with a slightly higher rate of complications than laparotomy. To perform a safe LC, it is important to exercise caution regarding an abnormal course for the hepatic artery, although the incidence itself is low. Here, we report a rare case of LC in which the medial segment artery mimicked cystic artery. To the best of our knowledge, such a case has not yet been reported. Case Presentation: A 35-year-old man visited our hospital with a complaint of epigastric pain. The symptom had continued for 2 months. Ultrasound and computed tomography revealed cholelithiasis. Magnetic resonance imaging did not show any biliary abnormalities. The patient was scheduled for an elective laparoscopic cholecystectomy. At the time of surgery, the gallbladder was slightly inflamed. After dissection of the Calot triangle, the cystic duct and a single large artery were identified. Although the critical view of safety was confirmed at first glance, dissection of periarterial adhesions revealed that the artery ran into the medial segment of the liver. Further dissection revealed short double cystic arteries branching from the aberrant artery. After the confirmation of the abnormal course of the arteries, the operation was performed safely without arterial injury. The patient made a satisfactory recovery and was discharged 3 days after operation. Conclusion: The knowledge of the anatomy of the cystic artery and careful dissection are an important aspect in achieving a complication-free LC.
- 1 October 2017
- Published by Elsevier in The American Journal of Surgery
- Vol. 214 (4) , 752-756
Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases
- 1 October 2017
- Published by Elsevier in The American Journal of Surgery
- Vol. 214 (4) , 752-756
Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases
- 1 August 2017
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 27 (4) , 267-272
The Effectiveness and Feasibility of Endoscopic Ultrasound-guided Transgastric Drainage of Postoperative Fluid Collections Early After Pancreatic Surgery
To assess the feasibility and usefulness of endoscopic ultrasound-guided transgastric drainage (EUS-GD) in patients who required early postoperative drainage of peripancreatic fluid collection or postoperative pancreatic fistulas after pancreatic surgery. Between May 2012 and January 2016, 33 patients who developed peripancreatic fluid collection or postoperative pancreatic fistulas after pancreatic resection underwent EUS-GD or percutaneous drainage (PTD). Outcomes were compared retrospectively. The drainage procedures were performed on postoperative day 4 to 71 (median, 12) in the EUS-GD group, and 7 to 35 (median, 14) in the PTD group. Technical and clinical success rates reached 92% (11/12) in the EUS-GD group, and 100% (21/21) in the PTD group with no complications or mortality. The duration of hospital stay after drainage was 10 to 44 (median, 15) days for EUS-GD, compared with 10 to 39 (median, 21) days for PTD. EUS-GD is a safe and useful method for early drainage, which could be a good alternative to PTD.
- 1 August 2017
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 27 (4) , 267-272
The Effectiveness and Feasibility of Endoscopic Ultrasound-guided Transgastric Drainage of Postoperative Fluid Collections Early After Pancreatic Surgery
To assess the feasibility and usefulness of endoscopic ultrasound-guided transgastric drainage (EUS-GD) in patients who required early postoperative drainage of peripancreatic fluid collection or postoperative pancreatic fistulas after pancreatic surgery. Between May 2012 and January 2016, 33 patients who developed peripancreatic fluid collection or postoperative pancreatic fistulas after pancreatic resection underwent EUS-GD or percutaneous drainage (PTD). Outcomes were compared retrospectively. The drainage procedures were performed on postoperative day 4 to 71 (median, 12) in the EUS-GD group, and 7 to 35 (median, 14) in the PTD group. Technical and clinical success rates reached 92% (11/12) in the EUS-GD group, and 100% (21/21) in the PTD group with no complications or mortality. The duration of hospital stay after drainage was 10 to 44 (median, 15) days for EUS-GD, compared with 10 to 39 (median, 21) days for PTD. EUS-GD is a safe and useful method for early drainage, which could be a good alternative to PTD.
- Open Access
- 28 April 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (1) , 293-298
Glasgow prognostic score predicts therapeutic outcome after hepatic resection for hepatocellular carcinoma
Systemic inflammation, as evidenced by the Glasgow prognostic score (GPS), predicts cancer‑specific survival in various cancer types. The aim of this study was to evaluate the significance of the GPS in the therapeutic outcome of the patient following surgical resection for hepatocellular carcinoma. In total, 144 patients underwent surgical resection for hepatocellular carcinoma. For the assessment of systemic inflammatory response using the GPS, patients were classified into three groups: Patients with normal serum albumin (<3.5 g/dl) and normal serum C‑reactive protein (CRP) (≤1.0 mg/dl) were classified as GPS 0 (n=76), those with low serum albumin (1.0 mg/dl) were classified as GPS 1 (n=58), and those with low serum albumin (1.0 mg/dl) were classified as GPS 2 (n=10). Retrospectively, the relationship between patient characteristics including GPS, disease‑free as well as overall survival were investigated. In disease‑free survival, GPS 2 (P=0.019), with a tumor number ≥3 (P=0.004), and positive portal or venous invasion (P=0.034) were independent predictors of cancer recurrence in multivariate analysis. In overall survival, GPS 1 (P=0.042), GPS 2 (P<0.001) and positive portal or venous invasion (P<0.001) were independent predictors of poor patient outcome according to multivariate analysis. To conclude, the GPS in patients with hepatocellular carcinoma is an independent prognostic predictor after hepatic resection.
- 28 April 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (1) , 293-298
Open AccessGlasgow prognostic score predicts therapeutic outcome after hepatic resection for hepatocellular carcinoma
Systemic inflammation, as evidenced by the Glasgow prognostic score (GPS), predicts cancer‑specific survival in various cancer types. The aim of this study was to evaluate the significance of the GPS in the therapeutic outcome of the patient following surgical resection for hepatocellular carcinoma. In total, 144 patients underwent surgical resection for hepatocellular carcinoma. For the assessment of systemic inflammatory response using the GPS, patients were classified into three groups: Patients with normal serum albumin (<3.5 g/dl) and normal serum C‑reactive protein (CRP) (≤1.0 mg/dl) were classified as GPS 0 (n=76), those with low serum albumin (1.0 mg/dl) were classified as GPS 1 (n=58), and those with low serum albumin (1.0 mg/dl) were classified as GPS 2 (n=10). Retrospectively, the relationship between patient characteristics including GPS, disease‑free as well as overall survival were investigated. In disease‑free survival, GPS 2 (P=0.019), with a tumor number ≥3 (P=0.004), and positive portal or venous invasion (P=0.034) were independent predictors of cancer recurrence in multivariate analysis. In overall survival, GPS 1 (P=0.042), GPS 2 (P<0.001) and positive portal or venous invasion (P<0.001) were independent predictors of poor patient outcome according to multivariate analysis. To conclude, the GPS in patients with hepatocellular carcinoma is an independent prognostic predictor after hepatic resection.
- 1 November 2016
- Published by Wolters Kluwer Health in Pancreas
- Vol. 45 (10) , 1474-1477
The Decline of Amylase Level of Pancreatic Juice After Pancreaticoduodenectomy Predicts Postoperative Pancreatic Fistula
Objectives Postoperative pancreatic fistula (POPF) is a life-threatening complication after pancreaticoduodenectomy (PD). The aim of this study is to evaluate the significance of pancreatic amylase level of pancreatic juice for PF after PD. Methods The subjects were 46 patients who underwent PD between January 2012 and August 2015 at Jikei University Hospital. We retrospectively investigated the relation between patient characteristics including pancreatic amylase level of pancreatic juice through the pancreatic drainage tube and the incidence of POPF (grade B or grade C according to the International Study Group on the Pancreatic Fistula) using univariate and multivariate analyses. The decline of pancreatic amylase level of pancreatic juice was evaluated by 1 − postoperative day 3/postoperative day 1 ratio. Results In univariate analysis, nonductal adenocarcinoma (P = 0.0252), soft pancreatic remnant (P = 0.0155), and decline of pancreatic amylase level of pancreatic juice ≥ 80% (P = 0.0010) were significant predictors of POPF. In multivariate analysis, decline of pancreatic amylase level of pancreatic juice of 80% or greater (P = 0.0192) was the only significant independent parameter. Conclusions Decline of pancreatic amylase level of pancreatic juice can predict POPF after PD.
- 1 November 2016
- Published by Wolters Kluwer Health in Pancreas
- Vol. 45 (10) , 1474-1477
The Decline of Amylase Level of Pancreatic Juice After Pancreaticoduodenectomy Predicts Postoperative Pancreatic Fistula
Objectives Postoperative pancreatic fistula (POPF) is a life-threatening complication after pancreaticoduodenectomy (PD). The aim of this study is to evaluate the significance of pancreatic amylase level of pancreatic juice for PF after PD. Methods The subjects were 46 patients who underwent PD between January 2012 and August 2015 at Jikei University Hospital. We retrospectively investigated the relation between patient characteristics including pancreatic amylase level of pancreatic juice through the pancreatic drainage tube and the incidence of POPF (grade B or grade C according to the International Study Group on the Pancreatic Fistula) using univariate and multivariate analyses. The decline of pancreatic amylase level of pancreatic juice was evaluated by 1 − postoperative day 3/postoperative day 1 ratio. Results In univariate analysis, nonductal adenocarcinoma (P = 0.0252), soft pancreatic remnant (P = 0.0155), and decline of pancreatic amylase level of pancreatic juice ≥ 80% (P = 0.0010) were significant predictors of POPF. In multivariate analysis, decline of pancreatic amylase level of pancreatic juice of 80% or greater (P = 0.0192) was the only significant independent parameter. Conclusions Decline of pancreatic amylase level of pancreatic juice can predict POPF after PD.
- 18 October 2016
- Published by Springer Nature in International Cancer Conference Journal
- Vol. 6 (1) , 29-34
Hepatic angiosarcoma mimicking hepatic epithelioid hemangioendothelioma: report of a case
A 78-year-old male was admitted to our hospital for treatment of multiple hepatic tumors, which were suspected as hepatic epithelioid hemangioendothelioma (HEHE) by percutaneous tumor needle biopsy. With a diagnosis of HEHE, the patient underwent hepatic resection. In pathological findings, the tumor was composed of numerous endothelial cells without epithelioid cells, and was diagnosed as hepatic angiosarcoma (HAS). The patient received percutaneous radiofrequency ablation for recurrent HAS at 5 and 25 months postoperatively, and remains well with recurrence as of 28 months after the primary hepatic resection. In spite of improvement in radiological imaging, preoperative differential diagnosis between HAS and other malignant vascular tumors of the liver is still difficult. We herein report a case of HAS mimicking HEHE, treated successfully.
- 18 October 2016
- Published by Springer Nature in International Cancer Conference Journal
- Vol. 6 (1) , 29-34
Hepatic angiosarcoma mimicking hepatic epithelioid hemangioendothelioma: report of a case
A 78-year-old male was admitted to our hospital for treatment of multiple hepatic tumors, which were suspected as hepatic epithelioid hemangioendothelioma (HEHE) by percutaneous tumor needle biopsy. With a diagnosis of HEHE, the patient underwent hepatic resection. In pathological findings, the tumor was composed of numerous endothelial cells without epithelioid cells, and was diagnosed as hepatic angiosarcoma (HAS). The patient received percutaneous radiofrequency ablation for recurrent HAS at 5 and 25 months postoperatively, and remains well with recurrence as of 28 months after the primary hepatic resection. In spite of improvement in radiological imaging, preoperative differential diagnosis between HAS and other malignant vascular tumors of the liver is still difficult. We herein report a case of HAS mimicking HEHE, treated successfully.
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 223 (4) , e142
Pomalidomide Enhanced Antitumor Effect of Gemcitabine and Nab-Paclitaxel for Pancreatic Cancer Cells
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 223 (4) , e142
Pomalidomide Enhanced Antitumor Effect of Gemcitabine and Nab-Paclitaxel for Pancreatic Cancer Cells
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 223 (4) , e46
Initial Report of Phase II Study of Adjuvant Chemotherapy of Gemcitabine with Nafamostat Mesilate for Pancreatic Cancer
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 223 (4) , e46
Initial Report of Phase II Study of Adjuvant Chemotherapy of Gemcitabine with Nafamostat Mesilate for Pancreatic Cancer
- 1 July 2016
- Vol. 36 (7) , 3505-10
Assessment of Outcome After Pancreaticoduodenectomy by Junior Surgeons.
Pancreaticoduodenectomy (PD) is one of the most complicated procedures. We retrospectively assessed the therapeutic outcome after PD by Junior surgeons. This study included 253 patients. We retrospectively analyzed surgical outcomes and long-term survivals of PDs performed by Junior surgeons (surgical training year within 10 years) as compared to those by Senior surgeons (surgical training year over 10 years). Operative time was significantly longer in junior surgeons than that in Senior surgeons (p<0.001). Intraoperative blood loss (p=0.079), hospital stay (p=0.803), complications (p=0.700), mortality (p=0.442) were comparable between the two groups. Disease-free and overall survival rates were not statistically different between the two groups in pancreatic cancer (p=0.248 and p=0.526) and in bile duct or ampullary cancer (p=0.873 and p=0.954). PD performed by Junior surgeons require approximately 70 more minutes but surgery can be performed safely under appropriate patient selection, intraoperative supervision and perioperative management with comparable long-term survival.
- 1 July 2016
- Vol. 36 (7) , 3505-10
Assessment of Outcome After Pancreaticoduodenectomy by Junior Surgeons.
Pancreaticoduodenectomy (PD) is one of the most complicated procedures. We retrospectively assessed the therapeutic outcome after PD by Junior surgeons. This study included 253 patients. We retrospectively analyzed surgical outcomes and long-term survivals of PDs performed by Junior surgeons (surgical training year within 10 years) as compared to those by Senior surgeons (surgical training year over 10 years). Operative time was significantly longer in junior surgeons than that in Senior surgeons (p<0.001). Intraoperative blood loss (p=0.079), hospital stay (p=0.803), complications (p=0.700), mortality (p=0.442) were comparable between the two groups. Disease-free and overall survival rates were not statistically different between the two groups in pancreatic cancer (p=0.248 and p=0.526) and in bile duct or ampullary cancer (p=0.873 and p=0.954). PD performed by Junior surgeons require approximately 70 more minutes but surgery can be performed safely under appropriate patient selection, intraoperative supervision and perioperative management with comparable long-term survival.